Dotmatics Releases Powerful Enhancements to its Biology Solution
Dotmatics has released an enhanced version of its Biology Solution, a comprehensive biologics data management and analysis tool that integrates user-friendly visualization and bioinformatics features to streamline workflows in biopharma, industrial biotech, and AgTech, enabling scientists to efficiently manage molecular cloning, vector design, protein production, and biologics registration within a unified platform that connects data, scientific applications, and decision-making processes.
User-friendly visualization and bioinformatic tools offer rapid insights into complex data without the need for database experts and bioinformaticians.
Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, announced the availability of the latest version of its Biology Solution, an end-to-end biologics data management and analysis tool designed to help R&D leaders get more insight from their data, faster. The Biology Solution offers common workflows for scientists who work in biopharma, industrial biotech, and AgTech to accelerate new product development, simplify project management, and reduce the complexities of research IT infrastructure. The new version includes expanded functionality for molecular cloning and vector design, protein production, new biologics registration, and more.
The Biology Solution is the latest update to a suite of recently released Dotmatics Solutions, which are pre-configured packages of capabilities and workflows to support specific scientific disciplines. These solutions are powered by Dotmatics’ enterprise scientific platform, along with integrations to its popular scientific applications such as Geneious, SnapGene, and GraphPad Prism. These integrations enhance utility, improve data integrity, and reduce data transfer time for scientific experiments.
“For too long, the life sciences market has been without a digitally transformed lab, one that offers unified solutions for connecting the full lifecycle of science, data, and decision-making,” said Melanie Nelson, Director of Product Management, Solutions and Integrations at Dotmatics. “The Biology Solution facilitates the ability to capture all data in a single place and provides the structure needed to find and use that data later. Because we’ve developed a scalable, extensible, and configurable tool, scientists can bring their data together—from vector design to protein production to assays and more—and use all of that data to develop new strategies for drug discovery.”
Using the Biology Solution, customers benefit from knowing that data is integrated from the start. Dotmatics Data Discovery capabilities make it easy for scientists to find, manage, and leverage all of their data without the hassle of cross-collating multiple spreadsheets and common copy/paste errors and tedious spreadsheet management. In addition, the Biology Solution reduces time to implementation, enhances the customer’s drug discovery capabilities, and reduces internal data transfer requirements.
“With other ELNs we always felt like we hit a wall. We would think, ‘this is all the ELN can do for us,’ but with the Dotmatics Platform we definitely haven’t hit a wall, and I don’t foresee that happening any time soon,” said Chelsea Geruschat, Senior Research Associate in Downstream Process Development at Krystal Biotech. “I’m excited for the workflows Dotmatics is working on. What they’re developing will be really helpful for us in the future.”
The new Dotmatics Biology Solution can be used in a variety of biological research workflows, with use cases including, but not limited to:
- Molecular Cloning & Vector Design: Improve consistency and easily share vectors and sequences with colleagues. Design vectors in SnapGene or Geneious Prime, register and retrieve vectors and sequences from the biological registration system.
- Protein Production: Find all elements of the process in a single search. Produce common biologics, capture experimental details in an ELN, and track the production workflow—vectors, sequences, cell lines, expression conditions, purification results, and final batches are all tracked.
- Biologics Registration: Associate registered entities with experimental results, so you’ll know what’s in the tube. Register from the ELN, scientific applications like SnapGene and Geneious Prime, or directly in the registration system and track the location of samples in inventory.
- Experimental Data Capture: Capture results of characterization experiments and assays—reduce rework by tracking key information about what you’ve already made.
- Results Analysis: Make decisions using all of your stored data; search all stored data from one place, collate and analyze results from multiple experiments.
The new Biology Solution is available in two tiers: Enterprise or Enterprise Plus.
- Enterprise includes access to Dotmatics’ ELN and Data Discovery capabilities to support a broad array of biologics discovery. Customers can take advantage of biological registration directly from the Discovery ELN. They can also find enhanced results capture capabilities that make it easy to enter results in a structured way, ensuring they can be easily searched and retrieved in the future, and pre-built search forms for the common protein production workflow.
- Enterprise Plus includes everything in the Enterprise tier, plus Dotmatics screening capabilities for assays and more depth for specialized workflows used in antibody drug discovery.
About Dotmatics
Dotmatics is a leader in R&D scientific software connecting science, data, and decision-making. Its enterprise R&D platform and scientists’ favorite applications drive efficiency and accelerate innovation. More than 2 million scientists and 10,000 customers trust Dotmatics to help them create a healthier, cleaner, safer world. Dotmatics is a global team of more than 800 people dedicated to supporting its customers in over 180 countries. The company’s principal office is in Boston, with 14 offices and R&D teams located around the world.
Dotmatics is backed by Insight Partners, a leading global venture capital and private equity firm investing in high-growth technology and software scaleup companies. Learn more about Dotmatics, its platform, and applications including GraphPad Prism, Geneious, SnapGene, Protein Metrics, and LabArchives at https://dotmatics.com/.
Media Contact: Maggie Quale
Director of Public Relations
Dotmatics
+1 (831) 325-7943
Related
Simplify your laboratory workflow management with Dotmatics
Dotmatics offers a unified scientific R&D platform that streamlines laboratory workflow management by integrating various scientific applications, automating data extraction, cleaning, and harmonization into FAIR formats, thereby reducing manual data handling, enhancing collaboration, and accelerating the R&D cycle to help life sciences organizations bring new therapies to market faster.
The Rise of Biotech: Why Smaller Companies Are Outpacing Big Pharma on Innovation
Smaller biotech companies are increasingly outpacing big pharmaceutical firms in new molecular entity approvals due to their greater agility, willingness to take risks, and freedom to innovate despite funding challenges, with over half of upcoming blockbuster drug launches expected from first-time launchers who face higher risks but also potential for significant success.
Dotmatics Appoints Mike McKee as President and CEO
Dotmatics Ltd has appointed experienced technology CEO Mike McKee as its new President to accelerate the company's growth, scale its global team, double R&D investments, and lead integration efforts within Insightful Science's portfolio, succeeding founder Stephen Gallagher who will focus on strategic growth initiatives.
Four Moves Biotechs Can Make to Stay Competitive as Investor Confidence Shifts
As investor confidence in biotech has shifted from rapid, high-risk funding to more cautious, data-driven investment with longer timelines and stricter demands, biotechs must adapt by embracing innovative R&D platforms, demonstrating clear value through validated data and milestones, exploring flexible partnership models like co-development and joint ventures, and strategically managing growth to remain competitive in a market with tighter capital and evolving investor expectations.
Dotmatics Hosts Successful 2021 User Symposium
Dotmatics' 2021 virtual User Symposium featured leadership updates with Mike McKee as new CEO, customer presentations from major companies like Novo Nordisk emphasizing the need for updated, user-driven ELN systems with federated search capabilities, and provided attendees with insights and resources to enhance R&D through the Dotmatics platform.
Dotmatics Chemicals & Materials Science Software Demo
Dotmatics offers a comprehensive, end-to-end scientific software platform that digitizes and automates lab functions for chemicals and materials research, integrating best-in-class tools like GraphPad Prism and SnapGene to help over 2 million researchers overcome data challenges, improve decision-making, and accelerate R&D workflows.